Racetam
Phenylpiracetam
SaveA phenylated piracetam derivative developed in Russia for cosmonauts. Provides both cognitive and physical stimulation. Banned by WADA as a performance enhancer.
Quick verdict
The most stimulating racetam. Russian clinical data supports use in asthenia, cognitive impairment, and post-stroke recovery. WADA-banned, suggesting meaningful performance effects.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Russian trials show efficacy in post-stroke cognitive recovery, epilepsy (adjunctive), and asthenia. Cold tolerance enhancement was observed in the original cosmonaut research. Tolerance to stimulant effects develops with daily use. Banned by WADA since 2004.
Benefits
- Combined cognitive and physical stimulation
- Post-stroke recovery support in Russian trials
- Cold tolerance enhancement in original research
Dosage notes
100–200 mg once or twice daily. Best cycled (e.g., every other day or a few times weekly) to avoid tolerance.
Side effects
- Insomnia
- Irritability
- Headache
- Rapid tolerance to stimulant effects
Who should be cautious
WADA-banned substance. Tolerance develops rapidly to stimulant effects. Insomnia likely if dosed in the afternoon.
What this page cannot tell you
Russian trials are generally not replicated in Western settings. Stimulant tolerance limits chronic use.
Leaderboard scores
- Energy60
- Focus55
- Mood40
- Memory40
Write a review
Sign in to write a review.